The impact of Clinical Pharmacist Lead Collaborative Care on Quality Of Life of the Patients with Bipolar Disorder: A Unicenter Prospective, Randomization Study

Parihar, Ashish Singh; S, Ganachari Madiwalayya; Bheemsain, Tekkalaki; Wali, Shashikala C

doi:10.5530/ijper.51.2s.59

Cited by 3 publications

(4 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Six studies investigated changes in consumers' QOL. Different tools were used to assess QOL, but half of the studies (n = 3) used the WHO Quality of Life-BREF assessment and all showed significant QOL improvement (Mishra et al, 2017a(Mishra et al, , 2017bSingh et al, 2017).…”

Section: Quality Of Lifementioning

confidence: 99%

“…All RCTs had at least some concerns due to the nature of the intervention resulting in difficulty in blinding consumers and pharmacists. Six RCTs were assessed to have a high risk of bias relating to the 'measurement of the outcome' as they relied on self-report measures with non-blinded participants (Ahamad et al, 2019;Kaukab et al, 2015;Marques et al, 2013;Mishra et al, 2017aMishra et al, , 2017bSingh et al, 2017). Although there were 10 RCTs included in this review, only two specified the randomisation technique, and were rated as having low risk of bias in the randomisation process (Ahamad et al, 2019;Singh et al, 2017).…”

Section: Risk Of Biasmentioning

confidence: 99%

“…Six RCTs were assessed to have a high risk of bias relating to the 'measurement of the outcome' as they relied on self-report measures with non-blinded participants (Ahamad et al, 2019;Kaukab et al, 2015;Marques et al, 2013;Mishra et al, 2017aMishra et al, , 2017bSingh et al, 2017). Although there were 10 RCTs included in this review, only two specified the randomisation technique, and were rated as having low risk of bias in the randomisation process (Ahamad et al, 2019;Singh et al, 2017). The randomisation process of the other eight RCTs was not reported, potentially introducing selection bias.…”

Section: Risk Of Biasmentioning

confidence: 99%

See 2 more Smart Citations

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

El-Den

Stewart

et al. 2021

Aust N Z J Psychiatry

View full text Add to dashboard Cite

Objective: People living with severe and persistent mental illness experience poorer physical health, often due to medication and preventable lifestyle factors, and exacerbated by barriers to accessing healthcare services. Pharmacists are well-positioned to improve the physical and mental health of this population. However, little is known about pharmacists’ current practices when providing services to this population nor the impact of pharmacist-led interventions on consumer health outcomes. We undertook a systematic review to identify, describe and assess the effectiveness of pharmacist-led interventions for supporting people living with severe and persistent mental illness and the impact on consumer outcomes. Methods: MEDLINE, Embase, PsycINFO, CINAHL, Web of Science, Scopus, Cochrane Library, International Pharmaceutical Abstracts and ProQuest Dissertations and Theses were searched between January 1990 and April 2020. Full-text studies exploring pharmacist-led interventions in any setting for people living with severe and persistent mental illness were included. A risk of bias assessment was conducted. Results: A total of 37 studies were included. More than half of the pharmacist interventions were multifaceted. The most common components of pharmacist-led interventions included education and/or patient counselling, providing recommendations to healthcare professionals and conducting medication reviews. Multifaceted interventions demonstrated improvements in clinical outcomes, whereas single interventions focused mostly on consumer-reported outcomes. The methodological quality of included studies was moderate-to-high risk of bias and there was considerable heterogeneity in the study design, interventions described, and outcomes reported. Conclusion: There is evidence that pharmacist-led interventions improve consumer-reported and clinical outcomes for people living with severe and persistent mental illness. Pharmacists are capable and have a role in supporting people living with severe and persistent mental illness, either individually or as interprofessional collaborators with other healthcare professionals. Future research should attempt to better understand which particular intervention components have the greatest impact and also evaluate the implementation and long-term sustainability of such interventions.

show abstract

Section: Quality Of Lifementioning

confidence: 99%

Section: Risk Of Biasmentioning

confidence: 99%

Section: Risk Of Biasmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

El-Den

Stewart

et al. 2021

Aust N Z J Psychiatry

View full text Add to dashboard Cite

show abstract

“…Which implies the patients quality of life through mood swings, personal suffering. Uneven sociological behavior and distinguished family relationship 8 . In India, there is 200 bipolar disorder sufferer per 100,000 population 9 .…”

Section: Quick Response Codementioning

confidence: 99%

Untitled

2019

IJPSR

View full text Add to dashboard Cite

Background: Bipolar disorder is a chronic mental illness due to a different interval of manic and depressive phase, the patient may become more prone to DRP, which interfere with the patients' health outcome. Hence, clinical pharmacist can contribute to managing the DRP through proper pharmaceutical care intervention. Method/Design: A prospective, observational study had been done with 286 participants to assess, monitor, and resolve the DRP through Clinical Pharmacist intervention. Patients with Bipolar disorder, aged 18 to 65, included in the study except for the patient with other comorbid condition, lactating mothers, and pregnant women. Results: DRP in between, all the patients were observed, of which 70.9 % were drug-drug interaction followed by 29.1% ADR. The two major causes of DRP were at drug/dose selection level 95.5%, followed by a drug use process level 4.5%. Pharmacist intervention has been proposed at prescriber level, of which majority of interventions 52.7% had been accepted by the prescriber. Conclusion: In our study, the majority of DRP 64.7%, had been resolved due to the clinical pharmacist intervention, which shows that participation of clinical pharmacist in psychiatric setting may help to resolve the DRP and integrate the health care delivery system.

show abstract

Association of pharmacist intervention counseling with medication adherence and quality of life: A systematic review and meta-analysis of randomized trials

Kelly¹,

Ho²,

Smith³

et al. 2023

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

The impact of Clinical Pharmacist Lead Collaborative Care on Quality Of Life of the Patients with Bipolar Disorder: A Unicenter Prospective, Randomization Study

Cited by 3 publications

References 19 publications

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review

Untitled

Association of pharmacist intervention counseling with medication adherence and quality of life: A systematic review and meta-analysis of randomized trials

Contact Info

Product

Resources

About